Mylab Covid-19 antigen test kit Pathocatch gets ICMR nod, to be priced around Rs 450
The kit will be available for orders immediately and will be priced around Rs 450, it added.
New Delhi: Pune-based Mylab Discovery Solutions on Wednesday said it has received commercial approval from the Indian Council for Medical Research (ICMR) for its antigen testing kit for COVID-19.
The product named, ''Pathocatch COVID-19 Antigen Rapid testing kit'', is developed and manufactured in India, Mylab said in a statement.
The kit will be available for orders immediately and will be priced around Rs 450, it added.
The development adds another product to the company''s suite of testing solutions for COVID-19 virus, Mylab said.
"After bringing an affordable RT-PCR test to reduce dependence on foreign kits, we launched Compact XL to accelerate COVID-19 testing. Now, with the approval for an antigen testing kit, we will cover the whole spectrum of COVID-19 testing and leave no stone unturned to fight this pandemic," Mylab Discovery Solutions MD Hasmukh Rawal said.
Health experts believe that to keep up with the pace of infections, India needs a combination of both antigen and RT-PCR testing, the statement said.
Read also: Mylab unveils Compact XL To Automate Molecular Diagnostic Tests For COVID-19
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd